meloxoral
dechra regulatory b.v. - meloxicam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation of inflammation and pain in chronic musculoskeletal disorders.dogsalleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.
meloxoral 1.5 mg/ml oral suspension for dogs
le vet beheer b.v. - meloxicam - meloxicam 1.5 g/litre - anti-inflammatory
meloxoral 0.5 mg/ml oral suspension for cats
le vet beheer b.v. - meloxicam - meloxicam 0.5 g/litre - anti-inflammatory
meloxoral 0.5 mg/ml oral suspension for cats
le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - cats
meloxoral 1.5 mg/ml oral suspension for dogs
le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - dogs
meloxoral 0.5 mg/ml oral suspension for cats
dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - cats
meloxoral 1.5 mg/ml oral suspension for dogs
dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - dogs
eloxioral- meloxicam suspension
henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - eloxioral oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive eloxioral oral suspension. do not use eloxioral oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.
meloxicam-dp meloxicam 15mg tablet blister pack
medis pharma pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam-dp meloxicam 7.5 mg tablet blister pack
medis pharma pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; maize starch; sodium citrate dihydrate; colloidal anhydrous silica; magnesium stearate - meloxicam-dp is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.